Royalty Pharma plc
DE ˙ MUN ˙ GB00BMVP7Y09
46,92 € ↑0,92 (2,01%)
2026-06-04
AKTIENPREIS
SecurityDE:RPD / Royalty Pharma plc
InstitutionUBS Group AG
Latest Disclosed Ownership1,812,203 shares
Latest Disclosed Value $ 86,931,378
UBS Group AG ownership in RPD / Royalty Pharma plc

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,812,203 shares of Royalty Pharma plc (DE:RPD) valued at $72,614,974 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 2,005,831 shares of Royalty Pharma plc. This represents a change in shares of -9.65% during the quarter. The current value of the position is $85,037,626 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (RPD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:RPD / Royalty Pharma plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,812,203 -193,628 -9.65 86,931 12.16 0.0130
2026-01-29 2025-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 2,005,831 464,233 30.11 77,505 42.51 0.0126
2025-11-13 2025-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,541,598 -665,167 -30.14 54,388 -31.60 0.0085
2025-08-14 2025-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 2,206,765 854,289 63.16 79,510 88.85 0.0138
2025-05-13 2025-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,352,476 -353,046 -20.70 42,103 -3.23 0.0077
2025-02-14 2024-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,705,522 88,037 5.44 43,508 -4.92 0.0080
2024-11-14 2024-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,617,485 332,365 25.86 45,759 35.03 0.0100
2024-08-14 2024-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,285,120 585,185 83.61 33,889 59.42 0.0084
2024-05-13 2024-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 699,935 -167,060 -19.27 21,257 -12.71 0.0053
2024-02-09 2023-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 866,995 122,555 16.46 24,354 20.54 0.0073
2023-11-09 2023-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 744,440 54,697 7.93 20,204 -4.71 0.0070
2023-08-11 2023-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 689,743 187,788 37.41 21,203 17.24 0.0072
2023-05-12 2023-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 501,955 -233,230 -31.72 18,085 -37.75 0.0066
2023-02-08 2022-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 735,185 243,324 49.47 29,055 47.00 0.0108
2022-11-10 2022-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 491,861 294,062 148.67 19,764 137.66 0.0087
2022-08-10 2022-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 197,799 -279,890 -58.59 8,316 -55.31 0.0034
2022-05-16 2022-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 477,689 26,579 5.89 18,610 3.52 0.0062
2022-02-14 2021-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 451,110 159,970 54.95 17,977 70.85 0.0051
2021-11-15 2021-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 291,140 -378,404 -56.52 10,522 -61.66 0.0033
2021-08-13 2021-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 669,544 225,011 50.62 27,445 41.54 0.0088
2021-05-12 2021-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 444,533 221,447 99.27 19,390 73.67 0.0064
2021-02-11 2020-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 223,086 169,536 316.59 11,165 395.56 0.0038
2020-11-12 2020-09-30 13F ROYALTY PHARMA SHS CL A G7709Q104 53,550 44,649 501.62 2,253 421.53 0.0008
2020-07-31 2020-06-30 13F ROYALTY PHARMA SHS CL A G7709Q104 8,901 8,901 432 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-01-29 2025-12-31 13F ROYALTY PHARMA SHS CLASS A Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-13 2025-09-30 13F ROYALTY PHARMA SHS CLASS A Call 60,000 0.00 2,117 -2.08 n/a n/a n/a
2025-08-14 2025-06-30 13F ROYALTY PHARMA SHS CLASS A Call 60,000 0.00 2,162 15.75 n/a n/a n/a
2025-05-13 2025-03-31 13F ROYALTY PHARMA SHS CLASS A Call 60,000 1,868 n/a n/a n/a
2023-11-09 2023-09-30 13F ROYALTY PHARMA SHS CLASS A Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-11 2023-06-30 13F ROYALTY PHARMA SHS CLASS A Call 60,000 1,844 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-01-29 2025-12-31 13F ROYALTY PHARMA SHS CLASS A Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-13 2025-09-30 13F ROYALTY PHARMA SHS CLASS A Put 32,800 0.00 1,157 -2.03 n/a n/a n/a
2025-08-14 2025-06-30 13F ROYALTY PHARMA SHS CLASS A Put 32,800 0.00 1,182 15.67 n/a n/a n/a
2025-05-13 2025-03-31 13F ROYALTY PHARMA SHS CLASS A Put 32,800 -34.40 1,021 -19.92 n/a n/a n/a
2025-02-14 2024-12-31 13F ROYALTY PHARMA SHS CLASS A Put 50,000 1,276 n/a n/a n/a
2021-11-15 2021-09-30 13F ROYALTY PHARMA SHS CLASS A Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-13 2021-06-30 13F ROYALTY PHARMA SHS CLASS A Put 150,000 6,149 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.